Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom
Figure 3
(a) Probabilistic sensitivity analyses for comparison of cost-effectiveness of pazopanib versus placebo. (b) Acceptability curve for comparison of cost-effectiveness of pazopanib versus placebo. QALYs: quality-adjusted life-years.
